Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: Analysis of a prospective risk stratification protocol in the intracoronary stenting and antithrombotic regimen (ISAR) Trial
Research output: Contribution to journal › Article › peer-review
93Scopus
citations
Fingerprint
Dive into the research topics of 'Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: Analysis of a prospective risk stratification protocol in the intracoronary stenting and antithrombotic regimen (ISAR) Trial'. Together they form a unique fingerprint.